Actively Recruiting
An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-20
96
Participants Needed
11
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is pilot, observational, retrospective, Italian multicenter study.
CONDITIONS
Official Title
An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed diagnosis of relapsed or refractory Diffuse Large B Cell Lymphoma (DLBCL)
- Received at least one dose of tafasitamab combined with lenalidomide under the Named Patient Program between April 2022 and December 2022
- Age 18 years or older at enrollment
- Signed written informed consent (if applicable)
You will not qualify if you...
- Received tafasitamab combined with lenalidomide as part of a clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
2
AO Sant'Anna e San Sebastiano di Caserta
Caserta, Caserta, Italy
Actively Recruiting
3
A.R.N.A.S. Garibaldi
Catania, Catania, Italy
Actively Recruiting
4
Azienda Ospedaliera Universitaria Arcispedale S. Anna
Ferrara, Italy
Actively Recruiting
5
Azienda Ospedaliero Universitaria Careggi
Florence, Italy, 50134
Actively Recruiting
6
Irccs Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
7
Azienda Ospedaliero-Universitaria Maggiore della Carità
Novara, Italy, 28100
Actively Recruiting
8
Azienda Ospedaliera Villa Sofia Cervello
Palermo, Italy, 90146
Actively Recruiting
9
Ospedale Guglielmo da Saliceto di Piacenza
Piacenza, Italy, 29100
Actively Recruiting
10
IRCCS- Istituto Nazionale Tumori Regina Elena
Roma, Italy, 00144
Actively Recruiting
11
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy, 00168
Actively Recruiting
Research Team
P
Pier Luigi Zinzani, MD
CONTACT
B
Beatrice Casadei, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here